Large VA Study Reveals What GLP-1 Drugs Actually Do to Your Pancreas
New VA database analysis sheds light on the contested link between GLP-1 receptor agonists and pancreatitis risk.
20 articles
New VA database analysis sheds light on the contested link between GLP-1 receptor agonists and pancreatitis risk.
New clinical trials show GLP-1 medications like Ozempic can reverse fatty liver disease in up to 62% of patients within 72 weeks.
A physician breaks down the expanding benefits of GLP-1 medications — from heart and kidney health to joints and cancer — and why tirzepatide wins.
Learn what glucose and ketones in your urine actually mean for your metabolic health and diabetes risk.
A new class of drugs targeting myostatin may preserve muscle during weight loss, changing body composition forever.
Thomas DeLauer explains how psyllium husk forms a gel barrier in your gut to physically slow glucose absorption and improve insulin sensitivity.
Retatrutide shows unprecedented weight loss results in phase 3 trials, but higher side effects may limit its advantage over existing medications.
New research reveals why high-intensity interval training outperforms moderate cardio for insulin sensitivity.
Brian Johnson's tirzepatide experiment sparked interest in microdosing GLP-1s for anti-aging, but evidence remains hypothetical with real risks.
Research shows maple syrup's unique antioxidant compounds may improve insulin sensitivity and reduce harmful visceral fat accumulation.
A leading GLP-1 researcher reveals what Ozempic and Mounjaro really treat, their benefits beyond weight loss, and how to use them safely.
New research reveals that robust insulin production after eating actually reduces disease risk, contrary to popular belief.
New research reveals how liver-focused strategies can improve insulin sensitivity while still eating carbohydrates.
Research reveals how this ancient spice's unique amino acid helps regulate insulin naturally without dangerous blood sugar crashes.
Discover how dietary fiber triggers gut bacteria to produce compounds that naturally increase GLP-1 and reduce hunger hormones.
New research reveals how fermentation transforms bread's metabolic effects, potentially reducing insulin resistance and digestive issues.
GLP-1 drugs shrink appetite but risk muscle loss and nutrient gaps. Here's what to eat before, during, and after treatment.
Major cardiovascular trial shows PCSK9 inhibitors prevent first heart attacks and strokes, plus new oral formulation makes treatment more accessible.
Thomas DeLauer reveals how glycine supports liver detoxification, boosts glutathione production, and enhances metabolic flexibility.
Science-backed protocols for HIIT, circadian eating, and sleep optimization to dramatically improve glucose regulation and longevity.